Diselenide-Based Dual-Responsive Prodrug as Pyroptosis Inducer Potentiates Cancer Immunotherapy. - Wan SC; Ye MJ; Yang QC; Zhang T; Zhang MJ; Ma XB; Xu JM; Wang S; Wu ZZ; Yang LL; Shen XM; Xu Z; et al. (Advanced healthcare materials, 2023)